HR0716 101ST GENERAL ASSEMBLY

HR0716 LRB101 20252 MST 69792 r

HOUSE RESOLUTION

WHEREAS, Cholangiocarcinoma (bile duct cancer) is a rare form of cancer that originates from the cells lining the bile ducts that play a key role in digestion; there are three types, Intrahepatic, extrahepatic, and perihilar; and

WHEREAS, There are approximately 12,000 Americans diagnosed each year in the United States, with numbers increasing yearly; the mortality rate has increased dramatically in the last decade; and

WHEREAS, Patients are typically diagnosed at a late stage due to no validated early method of detection; symptoms of jaundice, abdominal pain, itchy skin, and weight loss are symptoms that do not usually present till advanced disease progression; and

WHEREAS, Cholangiocarcinoma is a rare cancer; of the top eight deadliest cancers, seven are rare; rare cancers have a five-year survival rate under 50%, with the cholangiocarcinoma five-year survival rate being approximately 20%; and

WHEREAS, There is currently no cure for cholangiocarcinoma/bile duct cancer; and

WHEREAS, Kelly green is the color representing cholangiocarcinoma/bile duct cancer awareness; and

WHEREAS, Foundations, research and teaching hospitals, rare cancer advocate groups, and patient advocate groups from around the globe have joined together to recognize February 12, 2020 as World Cholangiocarcinoma Day; and

WHEREAS, Increased cholangiocarcinoma advocacy, awareness, research, and education will bring improved outcomes for patients in earlier detection and treatment and potential curative methods; therefore, be it

RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE ONE HUNDRED FIRST GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that we recognize February 12, 2020 as being World Cholangiocarcinoma Day.